Dr Evan Reid

University position
Wellcome Trust Senior Research Fellow
Dr Evan Reid is pleased to consider applications from prospective PhD students.
Departments
Department of Medical Genetics
Institutes
Cambridge Institute for Medical Research (CIMR)
Home page
http://www.cimr.cam.ac.uk/investi...
Research Theme
Interests
My group's research is focussed on the hereditary spastic paraplegias, genetic conditions where the corticospinal tract axons degenerate. HSPs selectively involve axons while sparing the neuronal cell bodies, so we study them to understand molecular mechanisms crucial for axonal maintenance and degeneration.
Our research has evolved from gene mapping and identification studies to concentrate on cell biological studies, particularly in the area of the role of HSP proteins in membrane traffic. The overall aim of this research is to understand the normal function of selected HSP proteins, to determine how abnormality of these functions leads to the disease, and to use this knowledge to rationally design new therapeutic strategies for the disorder.
Research Focus
KeywordsHereditary spastic paraplegia Membrane traffic Axon Spastin Atlastin |
Clinical conditionsGenetic disorders Hereditary Spastic Paraplegias |
Equipment
Cell culture
Cellular functional assays
Confocal microscopy
Fluorescence microscopy
Protein purification
Recombinant protein expression
Collaborators
Cambridge |
Key publications
Wang X, Shaw RW, Tsang HT, Reid E, O’Kane CJ (2007), “Spichthyin, the Drosophila homolog of ichthyin and SPG6, is an inhibitor of BMP signaling, and can impair axonal transport” Nature Neuroscience 10:177-85
Sanderson CM, Connell JW, Edwards TL, Bright NA, Duley S, Thompson A, Luzio JP, Reid E (2006), “Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners” Human Molecular Genetics 15:307-18 Details
Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, Lennon Graham F, Gaskell PC, Dearlove A, Pericak-Vance M, Rubinsztein DC, Marchuk DA (2002), “A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10)” Am J Hum Genet 71:1189-94
Publications
2011
Blackstone C, O'Kane CJ, Reid E (2011), “Hereditary spastic paraplegias: membrane traffic and the motor pathway.” Nat Rev Neurosci 12(1):31-42 Details
Hopkins TG, Maher ER, Reid E, Marciniak SJ (2011), “Recurrent pneumothorax.” Lancet 377(9777):1624 Details
Schiel JA, Park K, Morphew MK, Reid E, Hoenger A, Prekeris R (2011), “Endocytic membrane fusion and buckling-induced microtubule severing mediate cell abscission.” J Cell Sci 124(Pt 9):1411-24 Details
2010
Harbour ME, Breusegem SY, Antrobus R, Freeman C, Reid E, Seaman MN (2010), “The cargo-selective retromer complex is a recruiting hub for protein complexes that regulate endosomal tubule dynamics.” J Cell Sci Details
2009
Connell JW, Lindon C, Luzio JP, Reid E (2009), “Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion.” Traffic 10(1):42-56 Details
Edwards TL, Clowes VE, Tsang HT, Connell JW, Sanderson CM, Luzio JP, Reid E (2009), “Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5.” Biochem J Details
Smith BN, Bevan S, Vance C, Renwick P, Wilkinson P, Proukakis C, Squitieri F, Berardelli A, Warner TT, Reid E, Shaw CE (2009), “Four novel SPG3A/atlastin mutations identified in autosomal dominant hereditary spastic paraplegia kindreds with intra-familial variability in age of onset and complex phenotype.” Clin Genet 75(5):485-9 Details
Tsang HT, Edwards TL, Wang X, Connell JW, Davies RJ, Durrington HJ, O'Kane CJ, Luzio JP, Reid E (2009), “The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signaling.” Hum Mol Genet Details
2007
Beetz C, Nygren AO, Deufel T, Reid E (2007), “An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion.” Neurogenetics 8(4):317-8 Details
Douglas J, Cilliers D, Coleman K, Tatton-Brown K, Barker K, Bernhard B, Burn J, Huson S, Josifova D, Lacombe D, Malik M, Mansour S, Reid E, Cormier-Daire V, Cole T, Childhood Overgrowth Collaboration, Rahman N (2007), “Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth.” Nat Genet 39(8):963-5 Details
Moumoulidis I, Axon P, Baguley D, Reid E (2007), “A review on the genetics of otosclerosis.” Clin Otolaryngol 32(4):239-47 Details
Valdmanis PN, Meijer IA, Reynolds A, Lei A, MacLeod P, Schlesinger D, Zatz M, Reid E, Dion PA, Drapeau P, Rouleau GA (2007), “Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia.” Am J Hum Genet 80(1):152-61 Details
2006
Kersey JP, Vivian AJ, Reid E (2006), “A report of paracentric inversion of chromosome 8 in Moebius syndrome.” Ophthalmic Genet 27(1):29-31 Details
Tsang HT, Connell JW, Brown SE, Thompson A, Reid E, Sanderson CM (2006), “A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex.” Genomics 88(3):333-46 Details
2005
Reid E, Connell J, Edwards TL, Duley S, Brown SE, Sanderson CM (2005), “The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B.” Hum Mol Genet 14(1):19-38 Details
2004
Shaw-Smith CJ, Lewis SJ, Reid E (2004), “X-linked adrenoleukodystrophy presenting as autosomal dominant pure hereditary spastic paraparesis.” J Neurol Neurosurg Psychiatry 75(5):686-8 Details
2003
Blumen SC, Bevan S, Abu-Mouch S, Negus D, Kahana M, Inzelberg R, Mazarib A, Mahamid A, Carasso RL, Slor H, Withers D, Nisipeanu P, Navon R, Reid E (2003), “A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24-q32.” Ann Neurol 54(6):796-803 Details
King AL, Moodie SJ, Fraser JS, Curtis D, Reid E, Dearlove AM, Ciclitira PJ (2003), “Coeliac disease: investigation of proposed causal variants in the CTLA4 gene region.” Eur J Immunogenet 30(6):427-32 Details
Proukakis C, Auer-Grumbach M, Wagner K, Wilkinson PA, Reid E, Patton MA, Warner TT, Crosby AH (2003), “Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene.” Hum Mutat 21(2):170 Details
Reid E (2003), “Many pathways lead to hereditary spastic paraplegia.” Lancet Neurol 2(4):210 Details
Reid E (2003), “Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias.” J Med Genet 40(2):81-6 Details
Yip AG, Dürr A, Marchuk DA, Ashley-Koch A, Hentati A, Rubinsztein DC, Reid E (2003), “Meta-analysis of age at onset in spastin-associated hereditary spastic paraplegia provides no evidence for a correlation with mutational class.” J Med Genet 40(9):e106 Details
2002
King AL, Moodie SJ, Fraser JS, Curtis D, Reid E, Dearlove AM, Ellis HJ, Ciclitira PJ (2002), “CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families.” J Med Genet 39(1):51-4 Details
2001
Reid E, Escayg A, Dearlove AM, Meisler MH, Rubinsztein DC (2001), “The spastic paraplegia SPG10 locus: narrowing of critical region and exclusion of sodium channel gene SCN8A as a candidate.” J Med Genet 38(1):65-7 Details
2000
Baralle D, Dearlove AM, Beach R, Ffrench-Constant C, Reid E (2000), “Benign familial infantile convulsions: report of a UK family and confirmation of genetic heterogeneity.” J Med Genet 37(10):E31 Details
de Lange RP, Bolt J, Reid E, da Silva R, Shaw DJ, Clair DM (2000), “Screening British CADASIL families for mutations in the NOTCH3 gene.” J Med Genet 37(3):224-5 Details
Lindsey JC, Lusher ME, McDermott CJ, White KD, Reid E, Rubinsztein DC, Bashir R, Hazan J, Shaw PJ, Bushby KM (2000), “Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis.” J Med Genet 37(10):759-65 Details
Reid E, Dearlove AM, Osborn O, Rogers MT, Rubinsztein DC (2000), “A locus for autosomal dominant "pure" hereditary spastic paraplegia maps to chromosome 19q13.” Am J Hum Genet 66(2):728-32 Details
1999
Lowe GD, Rumley A, Woodward M, Reid E, Rumley J (1999), “Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables.” Thromb Haemost 81(6):918-24 Details
Reid E (1999), “The hereditary spastic paraplegias.” J Neurol 246(11):995-1003 Details
Reid E, Dearlove AM, Rhodes M, Rubinsztein DC (1999), “A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity.” Am J Hum Genet 65(3):757-63 Details
Reid E, Dearlove AM, Whiteford ML, Rhodes M, Rubinsztein DC (1999), “Autosomal dominant spastic paraplegia: refined SPG8 locus and additional genetic heterogeneity.” Neurology 53(8):1844-9 Details
Reid E, Grayson C, Rogers MT, Rubinsztein DC (1999), “Locus-phenotype correlations in autosomal dominant pure hereditary spastic paraplegia. A clinical and molecular genetic study of 28 United Kingdom families.” Brain 122 ( Pt 9):1741-55 Details
Reid E, Grayson C, Rubinsztein DC, Rogers MT, Rubinsztein JS (1999), “Subclinical cognitive impairment in autosomal dominant "pure" hereditary spastic paraplegia.” J Med Genet 36(10):797-8 Details
1998
Reid E, Douglas F, Crow Y, Hollman A, Gibson J (1998), “Autosomal dominant juvenile recurrent parotitis.” J Med Genet 35(5):417-9 Details
1997
Lowe GD, Rumley A, Woodward M, Reid E (1997), “Oral contraceptives and venous thromboembolism.” Lancet 349(9065):1623 Details
Reid E (1997), “Pure hereditary spastic paraplegia.” J Med Genet 34(6):499-503 Details
1996
Ahmed MA, Reid E, Cooke A, Arngrímsson R, Tolmie JL, Stephenson JB (1996), “Familial hemiplegic migraine in the west of Scotland: a clinical and genetic study of seven families.” J Neurol Neurosurg Psychiatry 61(6):616-20 Details
Reid E, Morrison N, Barron L, Boyd E, Cooke A, Fielding D, Tolmie JL (1996), “Familial Wolf-Hirschhorn syndrome resulting from a cryptic translocation: a clinical and molecular study.” J Med Genet 33(3):197-202 Details


